EGFR signaling was shown to promote tumor cell proliferation and survival, invasion and angiogenesis [12]–[14] and mediate resistance to treatment, including ionizing radiation in preclinical models [15]–[17]. The gene discussed is EGFR; the disease is neoplasm.